| Literature DB >> 26148781 |
Andrea Pisani Ceretti1,2, Nirvana Maroni3, Matteo Sacchi4, Stefano Bona5, Maria Rachele Angiolini6, Paolo Bianchi7, Enrico Opocher8, Marco Montorsi9.
Abstract
BACKGROUND: The treatment of colon cancer located in splenic flexure is not standardized. Laparoscopic approach is still considered a challenging procedure. This study reviews two Institutions experience in laparoscopic treatment of left colonic flexure cancer. Intraoperative, pathologic and postoperative data from patients undergoing laparoscopic splenic flexure resection were analyzed to assess oncological safety as well as early and medium-term outcomes.Entities:
Mesh:
Year: 2015 PMID: 26148781 PMCID: PMC4494171 DOI: 10.1186/s12876-015-0301-7
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Fig. 1Trocar positions
Fig. 2Division of left colic artery at his origin from inferior mesenteric artery
Fig. 3Intracorporeal stapling of side to side colo-colic anastomosis
Fig. 4Closure of the enterotomy with intracorporeal suture and knotting
Demographic data and stage distribution
| Patients (n.) | 23 |
| Age (years) | 70 ± 10.5 |
| Sex (male/female) | 9/14 |
| BMI (Kg/m2) | 24.4 ± 5.2 |
| ASA [ | 10-10-3 |
| Tumor site | |
| Distal transverse | 6 |
| Splenic flexure | 13 |
| Proximal descending | 4 |
| TNM stage (I, II, III) | 9-8-6 |
Comparison between totally laparoscopic operation and extracorporeal anastomosis
| Intracorporeal anastomosis | Extracorporeal anastomosis | |
|---|---|---|
| Patients (n.) | 7 | 16 |
| Mean operative time (min) | 250 ± 50 | 182 ± 43 |
| Lenght of the minilaparotomy (cm) | 5 ± 1 | 8 ± 2 |
| Hospital stay (days) | 8.0 ± 1.8 | 8.7 ± 7.5 |
Intraoperative, postoperative and pathologic data
| Tumor diameter (cm) | 3.8 + 2.3 |
| Distal margin (cm) | 11.5 ± 3.7 |
| Proximal margin (cm) | 6.5 ± 2.1 |
| Harvested nodes (n) | 20.8 ± 5.3 |
| Operative time (min) | 190 ± 49 |
| Blood loss (ml) | 55 ± 33 |
| Hospital stay (days) | 8.5 ± 6.3 |
| Conversions | 0 % |
| Morbidity | 8.7 % |
| 30-days mortality | 0 % |
| Follow-up (months) | 33 ± 17 |